v3.19.3
Consolidated Condensed Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 28, 2019
Sep. 29, 2018
Cash Flows From Operating Activities:    
Net Income $ 86,082 $ 34,318
Adjustments to Reconcile Net Income to Cash Provided By Operating Activities:    
Depreciation and Amortization 24,183 26,756
Provisions for Non-Cash Losses on Inventory and Receivables 4,613 2,432
Equity-based Compensation Expense 2,943 2,349
Deferred Tax Benefit (3,820) (1,536)
Net Gain on Sale of Businesses, Before Taxes (78,801) 0
Other (792) (507)
Cash Flows from Changes in Operating Assets and Liabilities, Excluding the Effects of Acquisitions:    
Accounts Receivable 23,423 (52,890)
Inventories (18,963) (15,768)
Accounts Payable (5,494) 571
Accrued Expenses (5,867) 4,977
Other Current Assets and Liabilities (697) (1,620)
Customer Advanced Payments and Deferred Revenue (3,266) 19,241
Income Taxes 5,581 (4,315)
Supplemental Retirement and Other Liabilities 1,116 1,351
Cash Provided By Operating Activities 30,241 15,359
Cash Flows From Investing Activities:    
Acquisition of Business, Net of Cash Acquired (21,785) 0
Proceeds on Sale of Businesses 104,792 0
Capital Expenditures (8,850) (12,416)
Other Investing Activities 0 (3,376)
Cash Provided By (Used For) Investing Activities 74,157 (15,792)
Cash Flows From Financing Activities:    
Proceeds from Long-term Debt 99,000 35,015
Payments for Long-term Debt (146,080) (47,116)
Purchase of Outstanding Shares for Treasury (50,000) 0
Debt Acquisition Costs 0 (516)
Proceeds from Exercise of Stock Options 423 283
Other Financing Activities (1,284) 0
Cash Used For Financing Activities (97,941) (12,334)
Effect of Exchange Rates on Cash (284) (254)
Increase (Decrease) in Cash and Cash Equivalents 6,173 (13,021)
Cash and Cash Equivalents at Beginning of Period 16,622 17,914
Cash and Cash Equivalents at End of Period $ 22,795 $ 4,893

Source